CBSA GLOBAL PTE. LTD. – Trademark Portfolio
Entity Type: 24
CBSA GLOBAL PTE. LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BEE FIRST, CRANBERRY, CRANBERRY PRO, and THE SPECIALISTS' EDGE. The owner is based in SINGAPORE.
83, LORONG N TELOK KURAU, #02-07 NCLAVE
SINGAPORE 425265 , SG
Showing of trademarks Trademarks
Trademark Classifications
CBSA GLOBAL PTE. LTD.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CBSA GLOBAL PTE. LTD. have?
CBSA GLOBAL PTE. LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.
What trademark classes does CBSA GLOBAL PTE. LTD. file in?
CBSA GLOBAL PTE. LTD. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are CBSA GLOBAL PTE. LTD.'s most well-known trademarks?
CBSA GLOBAL PTE. LTD.'s registered trademark portfolio includes well-known marks such as BEE FIRST, CRANBERRY, CRANBERRY PRO, and THE SPECIALISTS' EDGE. These are among 6 currently registered trademarks in the portfolio.
What is CBSA GLOBAL PTE. LTD.'s trademark registration success rate?
CBSA GLOBAL PTE. LTD. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.